Servatus was established in 2012 and began operations in 2013. Servatus is an unlisted public company with headquarters in Queensland.
Servatus and an international joint-venture partner are building a state-of-the-art production and research facility at Coolum, Queensland to produce medical-grade biopharmaceuticals. The first stage of the facility was completed in 2019, and clinical trials are now underway.
The company derives its name from Saint Servatus, a churchman and diplomat in the 4th century AD, who became Bishop of Tongeren, a municipality now in modern-day Belgium. Servatus was invoked as a patron saint, with healing powers for a range of ailments, including rheumatism.